The prognostic importance of left atrial (LA) dysfunction is increasingly recognized. Magnetic resonance imaging can provide excellent visualization of the LA wall. We aimed to study the association of LA dysfunction measured using feature-tracking magnetic resonance imaging with incident adverse cardiovascular events among subjects with or without heart failure (HF) at baseline.
L
eft atrial (LA) enlargement has long been associated with worse cardiovascular morbidity and mortality. However, the importance of phasic LA function has more recently been recognized. [1] [2] [3] [4] [5] [6] [7] [8] LA dysfunction precedes the onset of heart failure (HF) in community-based cohorts 9 and has been reported in HF with reduced ejection fraction (HFrEF) 1, 3, 4 and HF with preserved ejection fraction (HFpEF). [2] [3] [4] [5] 10 Most prior studies utilized 2-dimensional echocardiography with or without speckle tracking to measure phasic LA function. Cardiac magnetic resonance (CMR) provides an excellent visualization of the LA wall, with high spatial resolution, using standard cine steady-state free-precession (SSFP) imaging. Furthermore, methods to measure LA longitudinal strain using novel featuretracking algorithms from standard CMR SSFP cine images have been recently developed. 9, 11, 12 In this study, we aimed to (1) compare indices of phasic LA function (based on phasic volumes and longitudinal LA strain measured using CMR) between subjects with HFpEF and HFrEF and subjects without HF; (2) assess the prognostic value of various measures of phasic LA function; (3) assess whether measures of phasic LA function are predictive of the risk of incident death or hospitalized HF events, independently of HF status at baseline, LA volume, left ventricular (LV) ejection fraction (LVEF), and LV mass measured with CMR.
METHODS
Because of regulatory constraints, the data, study materials, and analytic methods will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
We enrolled a convenience clinical sample of 640 subjects without HF (n=419), HFrEF (n=120) or HFpEF (n=101) referred for a CMR at the Corporal Michael J. Crescenz VA Medical Center. The protocol was approved by the Philadelphia VA Medical Center Institutional Review Board, and all subjects provided a written informed consent.
We defined HFrEF as symptomatic HF with an LVEF <50%. We defined HFpEF as: (1) New York Heart Association class II to IV symptoms consistent with HF, in the absence of significant aortic stenosis; (2) LVEF >50%; (3) mitral inflow E wave to annular tissue e′ ratio >14, 13 or at least 2 of the following: (a) mitral inflow E wave to annular tissue e′ ratio >8; (b) use of a loop diuretic for control of HF symptoms; (c) LA volume index >34 mL/m 2 of body surface area; (d) NT-proBNP (N-terminal pro-Btype natriuretic peptide)>200 pg/mL; (e) severe LV hypertrophy (LV mass index >149 g/m 2 in men and 122 g/m 2 in women).
14 Exclusion criteria were as follows: (1) claustrophobia; (2) metallic objects/implanted medical devices; and (3) other conditions, which would make study measurements less accurate (ie, atrial fibrillation or significant arrhythmia; inability to perform an adequate breath hold for CMR acquisitions).
A CMR study was performed, which was used for volumetric and LA strain analyses. The incidence of the composite end point of death or hospitalization for HF was ascertained during a median follow-up of 37.1 months via medical record review by trained physicians. Incident HF was identified by (1) a discharge diagnosis of decompensated HF; (2) presence of new-onset or worsening HF symptoms; (3) clinical or radiological evidence of pulmonary congestion, invasive evidence of increased LV filling pressures, or elevated natriuretic peptide levels (BNP [B-type natriuretic peptide] >300 ng/L or NT-proBNP >1000 ng/L).
CMR Protocol
A CMR was performed using a 1.5-Tesla whole-body magnetic resonance imaging (MRI) scanner (Avanto or Espree; Siemens, Malvern, PA) equipped with a phased-array cardiac coil. Balanced SSFP cine imaging was used to measure LV volumes and LVEF. Typical acquisition parameters were TR, 30.6 ms; TE, 1.3 ms; phases, 30; slice thickness, 8 mm; matrix size, 192×192; and parallel image (integrated parallel imaging techniques) factor, 2. Myocardial volume was measured as the difference between epicardial and endocardial volumes. LV mass was computed as myocardial volume multiplied by myocardial density.
Assessment of LA Function
Feature-tracking techniques for the measurement of LA phasic strain have previously been described. 11, 15 CVI42 software (Circle Cardiovascular Imaging, Inc, Calgary, Canada) was used to perform LA analyses. LA endocardial borders were manually traced in 2-and 4-chamber long-axis views using LV end diastole as reference phase. An automated tracking algorithm was applied, and manual adjustments were performed as needed to attain optimal wall tracking. An example of LA wall tracking in a study subject is depicted in Figure 1 .
CLINICAL PERSPECTIVE
Cardiac magnetic resonance provides an excellent visualization of the left atrial (LA) wall with high spatial resolution. Novel feature-tracking algorithms have been recently developed to measure LA strain using standard cardiac magnetic resonance cine images. We performed a comprehensive assessment of phasic LA function by traditional volumetric methods and feature tracking-derived LA longitudinal strain. We characterized the patterns of LA dysfunction in heart failure with reduced and preserved left ventricular ejection fraction. We also demonstrate that conduit and reservoir LA strain predict incident death and heart failure hospitalizations, independent of heart failure status, LA size, and left ventricular remodeling. Our findings indicate that a comprehensive assessment of LA function is feasible with standard contemporary magnetic resonance imaging techniques and provides incremental prognostic information for risk stratification of patients with and without heart failure.
Values of segmental deformation obtained using CVI42 software were exported and further processed using a custom software programmed in Python (Python Software Foundation, Wilmington, DE). We computed longitudinal atrial strain as (L 1 −L 0 )/L 0 , where L 1 is the change of atrial myocardial length throughout the atrial cycles and L 0 is the resting (or reference) length in a relaxed state at diastasis (end of atrial diastole; Figure 1 ). Strain rate (SR) was computed as the rate of change in longitudinal strain. Volumetric indices of phasic LA function were also computed using LA volumes during various phases (LA Max 
Statistical Methods
We first compared general clinical characteristics of patients without HF, HFrEF, and HFpEF. We used ANOVA with post hoc pairwise comparisons with Bonferroni correction for continuous variables. We used χ 2 tests or Fisher exact tests, as appropriate, for categorical variables. We also compared measures of LA strain between the groups using ANOVA; for adjusted analyses, we used ANCOVA. For all comparisons of continuous variables, normality was assessed with the Anderson-Darling test and log transformations were applied as needed to improve normality. In all cases, means and 95% CIs are expressed in the native (linear) scale. The prognostic value of various parameters was assessed using the Cox proportional hazards models. We assessed loglog plots, Schoenfeld and Martingale residuals to test the proportionality and linearity assumptions in Cox models. All hazard ratios (HRs) are standardized (ie, represent the relative risk per SD change in the predictor), to facilitate an intuitive comparison of the association between different indices of LA structure and function with the composite outcome. For multivariable Cox modeling, we prespecified key covariates that could: (1) contribute causally to LA dysfunction and (2) demonstrate independent associations with the risk of incident events. We adjusted our Cox models for LVEF, LV mass, HF status, age, sex, AfricanAmerican ethnicity, body mass index (BMI), systolic and diastolic blood pressure, hypertension, diabetes mellitus, and coronary artery disease. We also built Cox models after further adjustment for LA volume index. We built separate unadjusted and adjusted Cox models for each metric of LA function. Statistical significance was defined as a 2-tailed P value <0.05. All probability values presented are 2 tailed. Statistical analyses were performed using the Matlab statistics and machine learning toolbox (Mathworks, Natwick, MA) and SPSS for Mac v22 (SPSS, Inc, Chicago, IL). 
RESULTS
Baseline characteristics of study subjects stratified by HF status (HFrEF, HFpEF, and no HF) are presented in the Table. The groups were largely composed of older white and black male subjects with a significant burden of comorbidities. HFrEF and HFpEF subjects were slightly older than subjects without HF. There was a greater proportion of women in the HFpEF group and a smaller proportion in the HFrEF group. BMI and the prevalence of OSA were significantly higher in the HFpEF group, whereas the prevalence of diabetes mellitus was higher in both HF groups, compared with subjects without HF. Table I in the Data Supplement and Figure 2 show a comparison of measures of LA phasic function between the groups. There were significant differences in all volumetric and strain-based measures of indices of LA function.
Comparison of LA Function Between HF Groups
In post hoc pairwise comparisons, the majority of the LA function indices were impaired in HFrEF group, as compared with subjects without HF and those with HFpEF. However, only the LA expansion index (a measure of reservoir function) was significantly lower in HFpEF, compared with the group without HF. In analyses adjusted for age, sex, ethnicity, BMI, systolic and diastolic blood pressure, and history of hypertension, diabetes mellitus, and coronary artery disease (Table I in the Data Supplement; Figure I in the Data Supplement), between-group differences persisted in most indices of LA function. In these adjusted analyses, pairwise post hoc group comparisons consistently demonstrated lower LA function in HFrEF, whereas only the LA expansion index (a measure of reservoir function) and the active LAEmF (a measure of booster-pump function) were reduced in HFpEF (Table I in the Data Supplement; Figure I in the Data Supplement). Table I in the Data Supplement and Figure 3 demonstrate comparisons of LA phasic volumes (maximum, minimum, and diastatic LA volume) between the groups. The HFpEF group demonstrated greater LA volumes than subjects without HF, whereas the HFrEF group demonstrated greater LA volumes than subjects with HFpEF and subjects without HF. Figure II in the Data Supplement and Table I in the Data Supplement demonstrate analogous comparisons adjusted for age, sex, ethnicity, BMI, systolic and diastolic blood pressure, and history of hypertension, diabetes mellitus, and coronary artery disease. In general, statistical trends were not substantially affected by adjustment for these potential confounders. In sensitivity analyses that excluded subjects with more than mild left-sided valvular disease (318, 104, and 90 in the no-HF, HFrEF, and HFpEF groups, respectively), between-group comparisons demonstrated nearly identical results (not shown).
Prognostic Value of LA Function
During a median duration of 37.1 months, 76 subjects experienced an HF admission, 83 died (of which 31 deaths were cardiovascular deaths), and 135 experienced a composite event. Figure 4 and Table II in the Data Supplement demonstrate the results of proportional hazards models in which LA strain measures are assessed as predictors of death or hospitalization for HF.
In unadjusted analyses ( Figure 4A ; Table II in . HR values >1 for conduit SR, booster SR, and booster strain indicate that greater reductions in conduit and booster function were associated with worse outcomes. In contrast, HR values <1 for reservoir and conduit strains indicate that greater reductions in reservoir and conduit function were associated with worse outcomes. In analyses that adjusted for LVEF, LV mass, HF status, age, sex, ethnicity, BMI, systolic and diastolic blood pressure, history of hypertension, diabetes mellitus, and coronary artery disease ( Figure 4B ; Table II in Figure III in the Data Supplement shows Kaplan-Meier curves for tertiles of the 3 most robust identified predictors of outcomes: LA reservoir strain, conduit strain, and conduit SR.
DISCUSSION
In this prospective study, we comprehensively assessed phasic LA function among subjects with HFrEF and HFpEF and subjects without HF and assessed the association between measures of LA function and the incident composite outcome of HF admission or death. We utilized novel feature-tracking algorithms applied to CMR cine images and demonstrated abnormalities in conduit, booster-pump, and reservoir function in HFrEF, whereas HFpEF was associated only with abnormal volumetric-based measures of reservoir and booster-pump function in adjusted analyses. We report, for the first time, that MRI tissue tracking-based measures of LA conduit and reservoir function, but not boosterpump function, are associated with the risk of incident HF hospitalization and death, even after adjusting for multiple confounders, including maximum LA volume, HF status, LV mass, and LVEF. Our results indicate that LA dysfunction represents an important cardiac phenotype in patients with or at risk for HF and validate the prognostic implications of LA strain measured by feature-tracking methods applied to standard cine-SSFP CMR images. This method does not require additional scanning time and can be readily incorporated in the clinical workflow.
LA Phasic Function in HFrEF and HFpEF
Maximum LA volume is widely used as a measure of atrial remodeling and LV diastolic function, 17 but it is also significantly affected by LA preload. 18 Recent stud- Numbers represent means or geometric means (95% CIs) for continuous variables or counts (proportions) for categorical variables. ACE indicates angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BP, blood pressure; BMI, body mass index; BNP, B-type natriuretic peptide; CCB, calcium channel blocker; GFR, glomerular filtration rate; HDL, highdensity lipoprotein; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LDL, low-density lipoprotein; and OSA, obstructive sleep apnea.
ies suggest that minimum and diastatic LA volumes are more sensitive to changes in atrial afterload [19] [20] [21] and closely relate to atrial elastance. 22 We estimated LA phasic function using both volumetric measures and novel strain-based measures.
In line with prior observations using echocardiography, 23 we observed that LA volumes were significantly higher in HFrEF as compared with HFpEF, which were in turn higher than in subjects without HF. Similarly, using feature-tracking MRI, we found concordant impairment in all strain-based LA function measures in subjects with HFrEF. Some prior studies have assessed echocardiography-based phasic LA strain in HFrEF. Kurt et al 3 reported significant reductions in conduit and booster functions (strain and SR) among 25 subjects with HFrEF referred for right heart catheterization, compared with 20 subjects with HFpEF and 19 subjects with hypertensive heart disease. In contrast, Sanchis et al 4 reported significant impairments in booster SR, but not conduit SR, conduit strain, and booster strain, among 32 subjects with HFrEF compared with 43 controls. Our study included a substantially larger sample than previous studies (120 HFrEF subjects compared with 419 controls) and had greater statistical power to detect differences in LA function. In addition to the larger sample size, differences in the technique (MRI feature tracking versus echocardiography) and characteristics of enrolled subjects with HFrEF may account for the differences with the previous study by Sanchis et al.
In contrast to the presence of conduit, booster pump, and reservoir LA dysfunction in the HFrEF group, we observed significant reductions in volumetric measures 
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Chirinos et al; CMR LA Strain and Outcomes of and booster-pump function in the HFpEF group, when compared with the group without HF. Prior studies reported that measures of LA conduit and reservoir function are impaired, whereas booster-pump function is increased, in subjects with mild hypertension. 24 However, with progression of disease, booster function also declines and is associated with the onset of HF symptoms. 25, 26 In our study, ≈3/4 of subjects without HF had hypertension, and the mean systolic blood pressure in the group was 141 mm Hg. We note that hypertension is highly prevalent in HFpEF and that a group of older adults with a high prevalence of hypertension, rather than a healthy group, is a better comparator to assess disease-specific phenotypic abnormalities in HFpEF, because the latter approach may detect features of hypertension, rather than HFpEF. In our study, HFpEF subjects demonstrated similar conduit LA function but more impaired booster-pump function, compared with the non-HF group. These results are in line with the echocardiographic study by Morris et al, 27 which found significantly lower booster SR, reservoir strain, and SR in subjects with HFpEF versus those with asymptomatic diastolic dysfunction. In contrast, Santos et al 5 reported significant impairments in all phases of LA function among HFpEF subjects enrolled in the PARAMOUNT trial, compared with healthy controls (no hypertension, diabetes mellitus, or structural heart disease). Our findings, along with prior studies, 5, [24] [25] [26] [27] [28] support the notion that impaired conduit function already occurs in early stages of hypertensive heart disease, whereas reduced booster-pump function is associated with the progression to HFpEF.
28

Phasic LA Function As a Predictor of the Composite Outcome of Death or HF Admission
Measures of LA conduit and reservoir function were associated with an increased risk of HF hospitalization and death, independent of HF status, LA volume, and MRI-derived LV EF and LV mass (which represents the gold standard method for these LV phenotypes). In a nested-cohort analysis of the Multiethnic Study of Atherosclerosis, which included 112 participants with incident HF and 224 age-and sex-matched controls, Habibi et al 9 reported that CMR-measured reservoir and conduit strain, as well as total and passive LAEmF, were associated with incident HF, independent of clinical risk factors and LV mass. In the Dallas Heart Study, Gupta et al 29 reported an independent association of CMRderived total LAEmF (a volumetric measure of reservoir function, analogous to expansion index in our study) with incident mortality.
In contrast to these community-based studies, our study included a clinical cohort of participants with HFrEF, HFpEF, and no HF. We found that although both volumetric and strain-based measures of atrial function predict the composite outcome of death or HF hospitalization, the HRs were in general stronger for longitudinal strain-based measures of LA conduit, reservoir, and booster-pump function, compared with the analogous volumetric-based measures. In a sample of 210 patients with chronic hypertension who underwent a clinically indicated CMR, Kaminski et al 30 reported an association between active and total LAEmF with the composite end point of incident HF, mortality, and acute coronary syndrome in unadjusted analyses. Active LAEmF and other measures of booster-pump function (ie, booster strain and SR) were also associated with the composite outcome in our unadjusted analyses; however, this association was attenuated after adjustment for clinical risk factors, LA volume, LV mass and LVEF. In a sample of 664 patients with HF who underwent a clinically indicated CMR, Pellicori et al reported an independent association of total LAEmF with incident mortality over median follow-up of 2.4 years. However, unlike our study, they did not study the association of other volumetric measures of phasic LA function and did not assess LA longitudinal strain-based measures of phasic LA function. Two previous speckle-tracking echocardiography studies demonstrated an association between LA reservoir longitudinal strain and adverse outcomes in HFpEF. 6, 31 Overall, our study reports a comprehensive evaluation of the prognostic value of all phases of LA function assessed by feature-tracking MRI, demonstrating that LA conduit and reservoir function predicts incident death or HF admission, in a diverse group of subjects with HFrEF and HFpEF and without HF, independent of various clinical factors, LA size, and LV remodeling. Among functional indices examined, LA longitudinal reservoir strain, conduit strain, and conduit SR were the strongest predictors of outcomes. Conduit strain requires the precise identification of diastasis. In addition, conduit SR requires the additional step of time differentiation of the strain curve. In contrast, reservoir strain is much less sensitive to identification of diastasis and is readily measurable, even in subjects with atrial fibrillation. Therefore, reservoir longitudinal strain is favored as a strong and straightforward predictor of outcomes.
Strengths and Limitations
Our study has several strengths and limitations, which should be considered while interpreting the findings. We prospectively studied a relatively large clinical cohort and comprehensively assessed atrial phasic function using both volume-based methods, as well as indices of phase function derived from phasic longitudinal strain, measured using novel feature-tracking techniques. Our sample included subjects with both HFpEF and HFrEF and without HF, allowing us to assess LA function across the spectrum of HF and its prognostic value independent of HF status at baseline. Our multivariable models were adjusted for gold standard MRI measures of LV mass and LVEF, which in themselves are strong prognostic measures. Our study also has limitations. Consistent with the patient population at VA Medical Centers, our sample was composed predominantly of men, and further studies including larger proportions of women would be valuable. Our participants were selected by convenience sampling of patients referred for a CMR at our institution, and as such, our results might not be applicable to unselected clinical or community-based cohorts. Although feature-tracking algorithms have been validated for global strain in the LV, the thin LA wall makes the use of more established strain techniques more challenging for validation of feature tracking in the LA. We did not assess the potential role of future revascularization or the differential association between LA strain and hospitalizations for HFrEF versus HFpEF. This should be the focus of future research with larger samples and a greater number of incident HF events. Atrial function parameters had limited reproducibility. Exclusion of patients with atrial fibrillation in our study may have blunted the prognostic role of booster function, which is lost in the presence of atrial fibrillation and could contribute to incident HF events. Finally, although LA strain was predictive of the composite event outcome after adjustment for HF status, our study was not sufficiently powered for stratified analyses or for interaction analyses to test whether the prognostic value of LA function differs according to HF status at baseline. This should be the focus of future studies with larger samples.
Conclusions
Using feature-tracking algorithms applied to standard CMR cine images, we describe patterns of LA dysfunction in HFrEF and HFpEF and demonstrate that MRI tissue tracking-based measures of LA conduit and reservoir function, but not booster-pump function, are strongly associated with the risk of incident HF hospitalization and death, even after adjusting for multiple confounders, including maximum LA volume, HF status, LV mass, and LVEF. Our findings demonstrate the prognostic importance of LA dysfunction and validate the prognostic implications of LA strain measured by feature-tracking MRI methods applied to standard cine SSFP cardiac images. A comprehensive LA function assessment is feasible with standard contemporary MRI techniques and provides incremental prognostic information for risk stratification of patients with and without HF. Future studies should study the role of feature tracking-derived atrial strain for disease and therapeutic monitoring in HF.
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